自己多血小板血漿(PRP)のグローバル市場展望 2023年-2029年:P-PRP、L-PRP、PRF

■ 英語タイトル:Autologous Platelet Rich Plasma (PRP) Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23DC12259)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23DC12259
■ 発行日:2023年12月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医療
■ ページ数:78
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[自己多血小板血漿(PRP)のグローバル市場展望 2023年-2029年:P-PRP、L-PRP、PRF]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の自己多血小板血漿(PRP)市場規模と予測を収録しています。・世界の自己多血小板血漿(PRP)市場:売上、2018年-2023年、2024年-2029年
・世界の自己多血小板血漿(PRP)市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の自己多血小板血漿(PRP)市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「P-PRP」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

自己多血小板血漿(PRP)のグローバル主要企業は、Harvest Technologies、 DePuy Synthes、 Stryker、 Zimmer Biomet、 Arthrex、 Regen Lab、 Exactech、 Weigao、 Emcyte Corporation、 REV-MEDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、自己多血小板血漿(PRP)のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の自己多血小板血漿(PRP)市場:タイプ別、2018年-2023年、2024年-2029年
世界の自己多血小板血漿(PRP)市場:タイプ別市場シェア、2022年
・P-PRP、L-PRP、PRF

世界の自己多血小板血漿(PRP)市場:用途別、2018年-2023年、2024年-2029年
世界の自己多血小板血漿(PRP)市場:用途別市場シェア、2022年
・整形外科、形成外科、一般外科、その他

世界の自己多血小板血漿(PRP)市場:地域・国別、2018年-2023年、2024年-2029年
世界の自己多血小板血漿(PRP)市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における自己多血小板血漿(PRP)のグローバル売上、2018年-2023年
・主要企業における自己多血小板血漿(PRP)のグローバル売上シェア、2022年
・主要企業における自己多血小板血漿(PRP)のグローバル販売量、2018年-2023年
・主要企業における自己多血小板血漿(PRP)のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Harvest Technologies、 DePuy Synthes、 Stryker、 Zimmer Biomet、 Arthrex、 Regen Lab、 Exactech、 Weigao、 Emcyte Corporation、 REV-MED

*************************************************************

・調査・分析レポートの概要
自己多血小板血漿(PRP)市場の定義
市場セグメント
世界の自己多血小板血漿(PRP)市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の自己多血小板血漿(PRP)市場規模
世界の自己多血小板血漿(PRP)市場規模:2022年 VS 2029年
世界の自己多血小板血漿(PRP)市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの自己多血小板血漿(PRP)の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の自己多血小板血漿(PRP)製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:P-PRP、L-PRP、PRF
自己多血小板血漿(PRP)のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:整形外科、形成外科、一般外科、その他
自己多血小板血漿(PRP)の用途別グローバル売上・予測

・地域別市場分析
地域別自己多血小板血漿(PRP)市場規模 2022年と2029年
地域別自己多血小板血漿(PRP)売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Harvest Technologies、 DePuy Synthes、 Stryker、 Zimmer Biomet、 Arthrex、 Regen Lab、 Exactech、 Weigao、 Emcyte Corporation、 REV-MED
...

This research report provides a comprehensive analysis of the Autologous Platelet Rich Plasma (PRP) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Autologous Platelet Rich Plasma (PRP) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Autologous Platelet Rich Plasma (PRP), challenges faced by the industry, and potential opportunities for market players.
The global Autologous Platelet Rich Plasma (PRP) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Autologous Platelet Rich Plasma (PRP) market presents opportunities for various stakeholders, including Orthopedic Surgery, Plastic Surgery. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Autologous Platelet Rich Plasma (PRP) market. Additionally, the growing consumer demand present avenues for market expansion.
The global Autologous Platelet Rich Plasma (PRP) market was valued at US$ 5170.5 million in 2022 and is projected to reach US$ 13020 million by 2029, at a CAGR of 14.7% during the forecast period.
Key Features:
The research report on the Autologous Platelet Rich Plasma (PRP) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Autologous Platelet Rich Plasma (PRP) market.
Market Overview: The report provides a comprehensive overview of the Autologous Platelet Rich Plasma (PRP) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., P-PRP, L-PRP), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Autologous Platelet Rich Plasma (PRP) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Autologous Platelet Rich Plasma (PRP) market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Autologous Platelet Rich Plasma (PRP) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Autologous Platelet Rich Plasma (PRP) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Autologous Platelet Rich Plasma (PRP) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Autologous Platelet Rich Plasma (PRP) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Autologous Platelet Rich Plasma (PRP), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Autologous Platelet Rich Plasma (PRP) market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Autologous Platelet Rich Plasma (PRP) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
P-PRP
L-PRP
PRF
Market segment by Application
Orthopedic Surgery
Plastic Surgery
General Surgery
Others
Global Autologous Platelet Rich Plasma (PRP) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Regen Lab
Exactech
Weigao
Emcyte Corporation
REV-MED
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Platelet Rich Plasma (PRP), market overview.
Chapter 2: Global Autologous Platelet Rich Plasma (PRP) market size in revenue and volume.
Chapter 3: Detailed analysis of Autologous Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Platelet Rich Plasma (PRP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Autologous Platelet Rich Plasma (PRP) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Autologous Platelet Rich Plasma (PRP) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autologous Platelet Rich Plasma (PRP) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autologous Platelet Rich Plasma (PRP) Overall Market Size
2.1 Global Autologous Platelet Rich Plasma (PRP) Market Size: 2022 VS 2029
2.2 Global Autologous Platelet Rich Plasma (PRP) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Autologous Platelet Rich Plasma (PRP) Sales: 2018-2029
3 Company Landscape
3.1 Top Autologous Platelet Rich Plasma (PRP) Players in Global Market
3.2 Top Global Autologous Platelet Rich Plasma (PRP) Companies Ranked by Revenue
3.3 Global Autologous Platelet Rich Plasma (PRP) Revenue by Companies
3.4 Global Autologous Platelet Rich Plasma (PRP) Sales by Companies
3.5 Global Autologous Platelet Rich Plasma (PRP) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Autologous Platelet Rich Plasma (PRP) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Autologous Platelet Rich Plasma (PRP) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autologous Platelet Rich Plasma (PRP) Players in Global Market
3.8.1 List of Global Tier 1 Autologous Platelet Rich Plasma (PRP) Companies
3.8.2 List of Global Tier 2 and Tier 3 Autologous Platelet Rich Plasma (PRP) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Autologous Platelet Rich Plasma (PRP) Market Size Markets, 2022 & 2029
4.1.2 P-PRP
4.1.3 L-PRP
4.1.4 PRF
4.2 By Type – Global Autologous Platelet Rich Plasma (PRP) Revenue & Forecasts
4.2.1 By Type – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2023
4.2.2 By Type – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2024-2029
4.2.3 By Type – Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
4.3 By Type – Global Autologous Platelet Rich Plasma (PRP) Sales & Forecasts
4.3.1 By Type – Global Autologous Platelet Rich Plasma (PRP) Sales, 2018-2023
4.3.2 By Type – Global Autologous Platelet Rich Plasma (PRP) Sales, 2024-2029
4.3.3 By Type – Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
4.4 By Type – Global Autologous Platelet Rich Plasma (PRP) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Autologous Platelet Rich Plasma (PRP) Market Size, 2022 & 2029
5.1.2 Orthopedic Surgery
5.1.3 Plastic Surgery
5.1.4 General Surgery
5.1.5 Others
5.2 By Application – Global Autologous Platelet Rich Plasma (PRP) Revenue & Forecasts
5.2.1 By Application – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2023
5.2.2 By Application – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2024-2029
5.2.3 By Application – Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
5.3 By Application – Global Autologous Platelet Rich Plasma (PRP) Sales & Forecasts
5.3.1 By Application – Global Autologous Platelet Rich Plasma (PRP) Sales, 2018-2023
5.3.2 By Application – Global Autologous Platelet Rich Plasma (PRP) Sales, 2024-2029
5.3.3 By Application – Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
5.4 By Application – Global Autologous Platelet Rich Plasma (PRP) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Autologous Platelet Rich Plasma (PRP) Market Size, 2022 & 2029
6.2 By Region – Global Autologous Platelet Rich Plasma (PRP) Revenue & Forecasts
6.2.1 By Region – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2023
6.2.2 By Region – Global Autologous Platelet Rich Plasma (PRP) Revenue, 2024-2029
6.2.3 By Region – Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
6.3 By Region – Global Autologous Platelet Rich Plasma (PRP) Sales & Forecasts
6.3.1 By Region – Global Autologous Platelet Rich Plasma (PRP) Sales, 2018-2023
6.3.2 By Region – Global Autologous Platelet Rich Plasma (PRP) Sales, 2024-2029
6.3.3 By Region – Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029
6.4.2 By Country – North America Autologous Platelet Rich Plasma (PRP) Sales, 2018-2029
6.4.3 US Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.4.4 Canada Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.4.5 Mexico Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029
6.5.2 By Country – Europe Autologous Platelet Rich Plasma (PRP) Sales, 2018-2029
6.5.3 Germany Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.4 France Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.5 U.K. Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.6 Italy Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.7 Russia Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.8 Nordic Countries Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.5.9 Benelux Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029
6.6.2 By Region – Asia Autologous Platelet Rich Plasma (PRP) Sales, 2018-2029
6.6.3 China Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.6.4 Japan Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.6.5 South Korea Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.6.6 Southeast Asia Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.6.7 India Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029
6.7.2 By Country – South America Autologous Platelet Rich Plasma (PRP) Sales, 2018-2029
6.7.3 Brazil Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.7.4 Argentina Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Autologous Platelet Rich Plasma (PRP) Sales, 2018-2029
6.8.3 Turkey Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.8.4 Israel Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.8.5 Saudi Arabia Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
6.8.6 UAE Autologous Platelet Rich Plasma (PRP) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Harvest Technologies
7.1.1 Harvest Technologies Company Summary
7.1.2 Harvest Technologies Business Overview
7.1.3 Harvest Technologies Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.1.4 Harvest Technologies Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.1.5 Harvest Technologies Key News & Latest Developments
7.2 DePuy Synthes
7.2.1 DePuy Synthes Company Summary
7.2.2 DePuy Synthes Business Overview
7.2.3 DePuy Synthes Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.2.4 DePuy Synthes Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.2.5 DePuy Synthes Key News & Latest Developments
7.3 Stryker
7.3.1 Stryker Company Summary
7.3.2 Stryker Business Overview
7.3.3 Stryker Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.3.4 Stryker Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.3.5 Stryker Key News & Latest Developments
7.4 Zimmer Biomet
7.4.1 Zimmer Biomet Company Summary
7.4.2 Zimmer Biomet Business Overview
7.4.3 Zimmer Biomet Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.4.4 Zimmer Biomet Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.4.5 Zimmer Biomet Key News & Latest Developments
7.5 Arthrex
7.5.1 Arthrex Company Summary
7.5.2 Arthrex Business Overview
7.5.3 Arthrex Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.5.4 Arthrex Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.5.5 Arthrex Key News & Latest Developments
7.6 Regen Lab
7.6.1 Regen Lab Company Summary
7.6.2 Regen Lab Business Overview
7.6.3 Regen Lab Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.6.4 Regen Lab Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.6.5 Regen Lab Key News & Latest Developments
7.7 Exactech
7.7.1 Exactech Company Summary
7.7.2 Exactech Business Overview
7.7.3 Exactech Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.7.4 Exactech Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.7.5 Exactech Key News & Latest Developments
7.8 Weigao
7.8.1 Weigao Company Summary
7.8.2 Weigao Business Overview
7.8.3 Weigao Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.8.4 Weigao Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.8.5 Weigao Key News & Latest Developments
7.9 Emcyte Corporation
7.9.1 Emcyte Corporation Company Summary
7.9.2 Emcyte Corporation Business Overview
7.9.3 Emcyte Corporation Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.9.4 Emcyte Corporation Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.9.5 Emcyte Corporation Key News & Latest Developments
7.10 REV-MED
7.10.1 REV-MED Company Summary
7.10.2 REV-MED Business Overview
7.10.3 REV-MED Autologous Platelet Rich Plasma (PRP) Major Product Offerings
7.10.4 REV-MED Autologous Platelet Rich Plasma (PRP) Sales and Revenue in Global (2018-2023)
7.10.5 REV-MED Key News & Latest Developments
8 Global Autologous Platelet Rich Plasma (PRP) Production Capacity, Analysis
8.1 Global Autologous Platelet Rich Plasma (PRP) Production Capacity, 2018-2029
8.2 Autologous Platelet Rich Plasma (PRP) Production Capacity of Key Manufacturers in Global Market
8.3 Global Autologous Platelet Rich Plasma (PRP) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autologous Platelet Rich Plasma (PRP) Supply Chain Analysis
10.1 Autologous Platelet Rich Plasma (PRP) Industry Value Chain
10.2 Autologous Platelet Rich Plasma (PRP) Upstream Market
10.3 Autologous Platelet Rich Plasma (PRP) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autologous Platelet Rich Plasma (PRP) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Autologous Platelet Rich Plasma (PRP) in Global Market
Table 2. Top Autologous Platelet Rich Plasma (PRP) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Autologous Platelet Rich Plasma (PRP) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Autologous Platelet Rich Plasma (PRP) Revenue Share by Companies, 2018-2023
Table 5. Global Autologous Platelet Rich Plasma (PRP) Sales by Companies, (K Units), 2018-2023
Table 6. Global Autologous Platelet Rich Plasma (PRP) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Autologous Platelet Rich Plasma (PRP) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Autologous Platelet Rich Plasma (PRP) Product Type
Table 9. List of Global Tier 1 Autologous Platelet Rich Plasma (PRP) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Platelet Rich Plasma (PRP) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2018-2023
Table 15. By Type - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2024-2029
Table 16. By Application – Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2018-2023
Table 20. By Application - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2024-2029
Table 21. By Region – Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Autologous Platelet Rich Plasma (PRP) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2018-2023
Table 25. By Region - Global Autologous Platelet Rich Plasma (PRP) Sales (K Units), 2024-2029
Table 26. By Country - North America Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2018-2023
Table 29. By Country - North America Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2024-2029
Table 30. By Country - Europe Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2024-2029
Table 34. By Region - Asia Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2024-2029
Table 38. By Country - South America Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2018-2023
Table 41. By Country - South America Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Sales, (K Units), 2024-2029
Table 46. Harvest Technologies Company Summary
Table 47. Harvest Technologies Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 48. Harvest Technologies Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Harvest Technologies Key News & Latest Developments
Table 50. DePuy Synthes Company Summary
Table 51. DePuy Synthes Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 52. DePuy Synthes Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. DePuy Synthes Key News & Latest Developments
Table 54. Stryker Company Summary
Table 55. Stryker Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 56. Stryker Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Stryker Key News & Latest Developments
Table 58. Zimmer Biomet Company Summary
Table 59. Zimmer Biomet Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 60. Zimmer Biomet Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Zimmer Biomet Key News & Latest Developments
Table 62. Arthrex Company Summary
Table 63. Arthrex Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 64. Arthrex Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Arthrex Key News & Latest Developments
Table 66. Regen Lab Company Summary
Table 67. Regen Lab Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 68. Regen Lab Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Regen Lab Key News & Latest Developments
Table 70. Exactech Company Summary
Table 71. Exactech Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 72. Exactech Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Exactech Key News & Latest Developments
Table 74. Weigao Company Summary
Table 75. Weigao Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 76. Weigao Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Weigao Key News & Latest Developments
Table 78. Emcyte Corporation Company Summary
Table 79. Emcyte Corporation Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 80. Emcyte Corporation Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Emcyte Corporation Key News & Latest Developments
Table 82. REV-MED Company Summary
Table 83. REV-MED Autologous Platelet Rich Plasma (PRP) Product Offerings
Table 84. REV-MED Autologous Platelet Rich Plasma (PRP) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. REV-MED Key News & Latest Developments
Table 86. Autologous Platelet Rich Plasma (PRP) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Autologous Platelet Rich Plasma (PRP) Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Autologous Platelet Rich Plasma (PRP) Production by Region, 2018-2023 (K Units)
Table 89. Global Autologous Platelet Rich Plasma (PRP) Production by Region, 2024-2029 (K Units)
Table 90. Autologous Platelet Rich Plasma (PRP) Market Opportunities & Trends in Global Market
Table 91. Autologous Platelet Rich Plasma (PRP) Market Drivers in Global Market
Table 92. Autologous Platelet Rich Plasma (PRP) Market Restraints in Global Market
Table 93. Autologous Platelet Rich Plasma (PRP) Raw Materials
Table 94. Autologous Platelet Rich Plasma (PRP) Raw Materials Suppliers in Global Market
Table 95. Typical Autologous Platelet Rich Plasma (PRP) Downstream
Table 96. Autologous Platelet Rich Plasma (PRP) Downstream Clients in Global Market
Table 97. Autologous Platelet Rich Plasma (PRP) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Autologous Platelet Rich Plasma (PRP) Segment by Type in 2022
Figure 2. Autologous Platelet Rich Plasma (PRP) Segment by Application in 2022
Figure 3. Global Autologous Platelet Rich Plasma (PRP) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autologous Platelet Rich Plasma (PRP) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Autologous Platelet Rich Plasma (PRP) Revenue, 2018-2029 (US$, Mn)
Figure 7. Autologous Platelet Rich Plasma (PRP) Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Autologous Platelet Rich Plasma (PRP) Revenue in 2022
Figure 9. By Type - Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 12. By Type - Global Autologous Platelet Rich Plasma (PRP) Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 16. By Application - Global Autologous Platelet Rich Plasma (PRP) Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 21. By Country - North America Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 23. US Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 28. Germany Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 29. France Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 37. China Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 41. India Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 44. Brazil Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Autologous Platelet Rich Plasma (PRP) Sales Market Share, 2018-2029
Figure 48. Turkey Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Autologous Platelet Rich Plasma (PRP) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Autologous Platelet Rich Plasma (PRP) Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Autologous Platelet Rich Plasma (PRP) by Region, 2022 VS 2029
Figure 54. Autologous Platelet Rich Plasma (PRP) Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23DC12259 )"自己多血小板血漿(PRP)のグローバル市場展望 2023年-2029年:P-PRP、L-PRP、PRF" (英文:Autologous Platelet Rich Plasma (PRP) Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。